Stocksigma LogoStocksigma Logo

Ajanta Pharma Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Crore)

■ Revenue: 1,794 (+32.5% YoY | +10.3% QoQ) ■ EBITDA: 548 (+67.0% YoY | +29.3% QoQ) ■ EBITDA Margin (%): 30.5 (+630 bps YoY | +447 bps QoQ) ■ PAT: 388

Ajanta Pharma Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Crore)

Ajanta Pharma Ltd · Outcome · 30 Oct 2026, 6:25 pm

Ajanta Pharma Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Crore) ■ Revenue: 1,794 (+32.5% YoY | +10.3% QoQ) ■ EBITDA: 548 (+67.0% YoY | +29.3% QoQ) ■ EBITDA Margin (%): 30.5 (+630 bps YoY | +447 bps QoQ) ■ PAT: 388 (+49.2% YoY | +16.1% QoQ) ■ EPS (INR): 31.0 (+49.0% YoY | +16.1% QoQ)

Original exchange filing (PDF)

More announcements from Ajanta Pharma Ltd

All Ajanta Pharma Ltd announcements